Digital Look

Welcome to Digital Look++,
you are not logged in

Regeneron Pharmaceuticals Inc. (REGN)

$ 774.61

Select chart: EPS | Revenue

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-21	16,071.70	9,325.80	7,640.00¢	8.3	0.1	+134%	n/a	0.0%
31-Dec-22	12,172.90	4,858.80	4,051.00¢	17.8	n/a	-47%	n/a	0.0%
31-Dec-23	13,117.20	4,199.30	3,705.00¢	23.7	n/a	-8%	n/a	0.0%
31-Dec-24	14,202.00	4,779.90	4,090.00¢	17.4	1.7	+10%	n/a	0.0%
31-Dec-25	14,342.90	5,230.70	4,307.00¢	17.9	3.6	+5%	n/a	0.0%

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-26	17,074.69	6,190.84	5,499.89¢	14.1	0.5	+28%	393.00¢	0.0%
31-Dec-26	17,074.69	6,190.84	5,499.89¢	14.1	0.5	+28%	393.00¢	0.0%
31-Dec-27	18,631.74	7,049.09	6,207.93¢	12.5	1.0	+13%	439.10¢	0.0%
31-Dec-27	18,631.74	7,049.09	6,207.93¢	12.5	1.0	+13%	439.10¢	0.0%

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	8.27	8.27	17.02	0.91

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.